COMMUNIQUÉS West-GlobeNewswire

Nicox : Initiation d'une étude de phase 2 pour le NCX 470 dans le glaucome à angle ouvert et l'hypertension oculaire

02/08/2018 - 07:31

Communiqué de presse Nicox : Initiation d'une étude de phase 2 pour le NCX 470 dans le glaucome à angle ouvert et l'hypertension oculaire ................................................. Etude randomisée sur 420 [...]

VALNEVA Delivers Strong IXIARO® Sales Growth and reports Further Progress on Key R&D Programs in H1

02/08/2018 - 07:02

Valneva Delivers Strong IXIARO ® Sales Growth and r eports Further Progress on Key R&D Programs in H1 Double-digit sales growth driven by IXIARO ® Product sales of €53.5 million in H1 2018, representing 11.4% year [...]

VALNEVA publie une forte croissance des ventes d'IXIARO® et avance sur ses programmes R&D clés au S1

02/08/2018 - 07:02

Valneva publie une forte croissance des ventes d'IXIARO ® et avance sur ses programmes R&D clés au S1 Croissance à deux chiffres des ventes soutenue par IXIARO ® Ventes de produits de €53,5 millions au S1 2018, [...]

argenx reports second quarter business update and half-year 2018 financial results

02/08/2018 - 07:01

Management to host conference call today at 3 p.m. CEST / 9 a.m. EDT August 2, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a [...]

BioCryst Pharmaceuticals Prices Public Offering of Common Stock

02/08/2018 - 03:59

RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today the pricing of an underwritten public offering of 9,090,910 shares of its common stock, [...]

Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange

02/08/2018 - 00:00

MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

La Jolla Pharmaceutical Company to Release Second Quarter 2018 Financial Results and Host a Webcasted Conference Call on August 8, 2018

01/08/2018 - 23:39

SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]

FibroGen to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018

01/08/2018 - 23:21

Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT) SAN FRANCISCO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a biopharmaceutical company, today announced that it will [...]

Intuitive Appoints Don Kania, Ph.D. to its Board of Directors

01/08/2018 - 22:58

SUNNYVALE, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery, today announced the appointment of [...]

Denali Therapeutics Announces Positive Clinical Results From LRRK2 Inhibitor Program for Parkinson’s Disease

01/08/2018 - 22:30

Healthy volunteer study of DNL201 meets all objectives in phase 1 clinical study, including CSF exposure levels and LRRK2 inhibition, as well as pathway engagement, at doses that were safe and well tolerated DNL201 will [...]

MyoKardia to Report Second Quarter 2018 Financial Results on Wednesday, August 8, 2018

01/08/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

01/08/2018 - 22:29

EMERYVILLE, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]

AxoGen, Inc. Reports 2018 Second Quarter Financial Results

01/08/2018 - 22:16

Q2 Revenue of $20.6 million, representing 36% growth over prior year; reiterates full year 2018 guidance ALACHUA, Fla., Aug. 01, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]

Conformis Announces the first 3D Total Hip Replacement Surgeries performed at JFK Medical Center in Florida

01/08/2018 - 22:15

The most advanced, patient conforming hip replacement system designed to enhance operational efficiency for the surgeon and improve patient outcomes BILLERICA, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. ( [...]

Zafgen to Present at the Canaccord Genuity 38th Annual Growth Conference

01/08/2018 - 22:15

BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

Globus Medical Reports Second Quarter 2018 Results

01/08/2018 - 22:15

AUDUBON, Pa., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018. Worldwide [...]

Inovalon Reports Second Quarter 2018 Results

01/08/2018 - 22:15

Second Quarter 2018 Highlights Second quarter revenue of $152.8 million Second quarter net loss of $10.5 million, resulting in net loss of $0.07 per share Second quarter Non-GAAP net income of $19.3 million, resulting [...]

AIT Therapeutics Schedules Fiscal First Quarter 2019 Financial Results Conference Call and Webcast

01/08/2018 - 22:15

Call scheduled for Tuesday, August 14 at 10:30am Eastern Time. NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on [...]

LeMaitre Vascular to Present at Upcoming Investor Conferences

01/08/2018 - 22:15

BURLINGTON, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two conferences in August. JJ Pellegrino, Chief Financial Officer, will [...]